Proteomics

Dataset Information

0

Human RNase 4 Improves mRNA Sequence Characterization by LC-MS/MS.


ABSTRACT: With the rapid growth of synthetic messenger RNA (mRNA)-based therapeutics and vaccines, the development of analytical tools for characterization of long, complex RNAs has become essential. Tandem liquid chromatography-mass spectrometry (LC-MS/MS) permits direct assessment of the mRNA primary sequence and modifications thereof without conversion to cDNA or amplification. It relies upon digestion of mRNA with site-specific endoribonucleases to generate pools of short oligonucleotides that are then amenable to MS-based sequence analysis. Here, we showed that the uridine-specific human endoribonuclease hRNase 4 improves mRNA sequence coverage, in comparison with the benchmark enzyme RNase T1, by producing a large population of uniquely mappable cleavage products. Furthermore, we deployed hRNase 4 to characterize mRNAs fully substituted with 1-methylpseudouridine (m1Ψ) or 5-methoxyuridine (mo5U), as well as mRNAs selectively depleted of uridine–two key strategies to reduce synthetic mRNA immunogenicity. Lastly, we demonstrated that hRNase 4 enables direct assessment of the 5′ cap incorporation in in vitro synthesized mRNA. Collectively, this study highlights the power of hRNase 4 to interrogate mRNA sequence, identity, and modifications by LC-MS/MS.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Synthetic Rna

SUBMITTER: Eric Wolf  

LAB HEAD: Ivan R. Correa Jr.

PROVIDER: PXD033334 | Pride | 2022-07-26

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2019-01-10 | PXD012094 | Pride
2022-08-18 | PXD029291 | Pride
2022-05-04 | PXD030845 | Pride
2022-06-01 | GSE195669 | GEO
2009-01-15 | E-GEOD-14361 | biostudies-arrayexpress
2022-12-09 | PXD034984 | Pride
2019-07-30 | GSE135049 | GEO
2020-03-31 | PXD016323 | Pride
2018-12-31 | PXD012097 | Pride
2022-12-09 | PXD027636 | Pride